期刊文献+

肝癌组织IFITM3蛋白表达水平及其与肝细胞癌患者手术切除术后肝内肿瘤复发的相关性分析 被引量:7

Expression of IFITM3 in hepatocellular carcinoma and its correlation with intrahepatic tumor recurence after hepatectomy
下载PDF
导出
摘要 目的探讨肝细胞癌(HCC)组织干扰素诱导跨膜蛋白3(IFITM3)表达水平及其临床意义。方法在我院接受根治性手术切除治疗的43例HCC患者,术中取癌组织和癌旁肝组织,分别采用Western blot法和免疫组化法检测组织IFITM3蛋白表达情况,比较肝内肿瘤复发与未复发患者癌组织IFITM3表达的差异。结果经Western blot法检测肝癌组织IFITM3表达水平为(1.2386±0.1901),显著高于癌旁组织的(0.9496±0.0995,t=8.832,P=0.000);免疫组化法检测显示肝癌组织IFITM3蛋白阳性率为72.1%(31/43),明显高于癌旁组织的14.0%(6/43,x^2=29.647,P=0.000);中分化肝癌组织IFITM3蛋白阳性率为90.9%(10/11),低分化肝癌组织为95.2%(20/21),均明显高于高分化组的9.1%(1/11)(x^2=14.727, P=0.000;x^2=23.748,P=0.000);术后复发组癌组织IFITM3蛋白阳性率为81.0%(17/21),未复发组为22.7%(5/22),两者比较差异具有统计学意义(x^2=14.578,P=0.000)。结论 HCC组织IFITM3蛋白呈高表达,且肝癌分化越差,IFITM3表达也越强,并可能与术后肿瘤复发有关。 Objective To investigate the expression of interferon-induced transmembrane protein (IFITM3) in hepatocellular carcinoma (HCC) and its correlation with intrahepatic tumor recurence after hepatectomy.Methods A total of 43 patients with HCC were recruited in our hospital,and all of them received hepatectomy.The specimens of cancer and its adjacent liver tissues were taken,and the expression of IFITM3 was detected by Western blot and by immunohistochemistry. All the patients were followed-up for 1 years. Results The expression of IFITM3 protein in HCC tissues was (1.2386±0.1901),significantly stronger than (0.9496±0.0995) in the adjacent tissues (t=8.832,P=0.000);the results of immunohistochemical staining showed that the brownish yellow granular IFITM3 protein located in the cytoplasm of liver cancer tissues and adjacent tissues,and the positive rate of IFITM3 protein in hepatocellular carcinoma was 72.1% (31/43),significantly higher than 14.0% (6/43) in adjacent tissues (x^2=29.647,P =0.000);the positive rate of IFITM protein in low and medium differentiated HCC tissues were 95.2% (20/21) and 90.9% (10/11),significantly higher than 9.1% (1/11) in high differentiated group (x^2=14.727,P=0.000;x^2=23.748,P=0.000);the positive rate of IFITM3 protein in patients with recurrent intrahepatic tumor was 81.0% (17/21),much higher than 22.7% (5/22) in without tumor recurrence (x^2=14.578,P=0.000).Conclusion IFITM3 protein is highly expressed in HCC tissues,and the worse the differentiation of HCC,the stronger the degree of expression,which might closely be related to the recurrence of HCC after hepatectomy.
作者 代晓楠 吕金燕 翁文采 郑丽丽 Dai Xiaonan;Lyu Jinyan;Weng Wencai(Department of Interventional Therapy,Xinhua Hospital Affiliated to Dalian University,Dalian 116021,Liaoning Province,China)
出处 《实用肝脏病杂志》 CAS 2019年第1期117-120,共4页 Journal of Practical Hepatology
基金 辽宁省自然科学基金资助项目(编号:2012010311-301)
关键词 肝细胞癌 干扰素诱导跨膜蛋白 3 肿瘤复发 免疫组化 Hepatoma Interferon-induced transmembrane protein Tumor recurrence Immunohistochemistry
  • 相关文献

参考文献7

二级参考文献61

  • 1童颖,杨甲梅.原发性肝癌的门静脉化疗进展[J].中国实用外科杂志,2005,25(2):116-118. 被引量:13
  • 2周信达,汤钊猷,余业勤,杨秉辉,马曾辰,陆继珍,林芷英,叶胜龙,吴志全.肝癌多模式治疗的远期疗效[J].中华外科杂志,1996,34(9):518-521. 被引量:34
  • 3Zhou Y,Sui C,Li B,et al.Repeat hepatectomy for recurrent hepatocellular carcinoma:a local experience and a systematic review[J].World J Surg Oncol,2010,8(55):1-10.
  • 4Chan DL,Morris DL,Chua TC.Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma-A systematic review[J].Surg Oncol,2013,22(2):23-30.
  • 5Itamoto T,Nakahara H,Amano H,et al.Repeat hepatectomy for recurrent hepatocellular carcinoma[J].Surgery,2007,141 (5):589-597.
  • 6Li Q,Wang J,Sun Y,et al.Efficacy of postoperative transarterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma complicated by portal vein tumor thrombosis-a randomized study[J].World J Surg,2006,30 (11):2004-2011.
  • 7Nagasue N,Yukaya H,Ogawa Y,et al.Second hepatic resection for recurrent hepatocellular carcinoma[J].Br J Surg,1986,73(6):434-437.
  • 8El-Serag HB,Rudolph KL.Hepatocellular carcinoma:epidemiology and molecular carcinogenesis[J].Gastroenterology,2007,132(7):2557-2576.
  • 9Arii S,Yamaoka Y,Futagawa S,et al.Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas:A retrospective and nationwide survey in Japan[J].Hepatology,2000,32(6):1224-1229.
  • 10Llovet JM,Real MI,Montana X,et al.Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:A randomised controlled trial[J].Lancet,2002,359(9319):1734-1739.

共引文献75

同被引文献61

引证文献7

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部